42000601
PRONOVA® UP VLVM
very low viscosity sodium alginate, viscosity <20 mPa.s, 1 %(20 °C)(low), mannuronate monomer units ≥50 %
Synonym(s):
Alginate / Alginic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.25
UNSPSC Code:
12162002
Quality Level
form
powder
mol wt
Mw <75 kDa (approximate)
composition
mannuronate monomer units, ≥50% , G/M ratio, ≥1.5
impurities
≤100 CFU/g Total viable count, ≤100 EU/g Endotoxins
pH
5.5-8.5 (20 °C, 1% in water)
viscosity
<20 mPa.s, 1 %(20 °C) (
low)
General description
PRONOVA UP VLVM is a very low viscosity (less than 20 mPas) sodium alginate where minimum 50% of the monomer units are mannuronate.
Application
Examples of Pronova Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.
Legal Information
Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.
Disclaimer
NOT FOR USE IN HUMANS
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 42000601-10G | 04065267988214 |
| 42000601-5G | 04065267988221 |